MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Striatal molecular alterations in Huntington’s disease gene expansion carriers: A systematic review and meta-analysis of PET studies

F. Niccolini, G. Pagano, P. Fusar-Poli, A. Wood, L. Mrzljak, C. Sampaio, M. Politis (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 1120

Keywords: Chorea (also see specific diagnoses, etc): Clinical features, Huntingtons disease, Positron emission tomography(PET)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Huntington's disease

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To systematically examine the evidence of striatal molecular alterations in premanifest and manifest Huntington’s disease gene expansion carriers (HDGECs) as measured by Positron emission tomography (PET) imaging studies.

Background: There is an urgent need to identify biomarkers able to monitor disease progression and assess the development and efficacy of novel disease-modifying therapies in HD. PET molecular imaging is a powerful tool for detecting molecular alterations in the brains of HDGECs.

Methods: MEDLINE, ISI Web of Science, Cochrane Library and Scopus electronic databases were searched for articles published until 23th November 2015 and included PET studies in premanifest and manifest HDGECs. PET binding in the striatum, caudate, and putamen, as well as demographic, clinical, and methodological variables, were extracted from each publication. PET ligands in premanifest and manifest HDGECs were compared with healthy controls and calculated as mean difference using Comprehensive Meta-Analysis software. Publication bias was assessed with funnel plots and Egger’s intercept. Heterogeneity was addressed with I2 index. Meta-regression analysis was performed to test age, gender, disease duration, CAG repeat, and quality of the study.

Results: Twenty PET studies investigating striatal dopamine, glucose metabolism, microglial activation and phosphodiesterase 10A (PDE10A) levels in manifest (n=191), premanifest (n=158) HDGECs and healthy controls (n=333) were included in a quantitative meta-analysis. In manifest and premanifest HDGECs, the largest mean differences were observed in striatal PDE10A and dopamine D2 receptor levels. Manifest HDGECs showed also significant decreases in striatal dopamine D1 receptor levels and glucose metabolism. Modest changes were found in striatal glucose metabolism and microglial activation in premanifest HDGECs.

Conclusions: The data suggest that decreases in striatal PDE10A and dopamine D2 receptor levels are the strongest molecular changes in both manifest and premanifest HDGECs according to the PET studies conducted to date. Despite 20 years of PET research in HDGECs, conclusions are limited and further studies are needed for building a signature of PET biomarkers across the stages of HD that could monitor disease progression and used as pharmacodynamic measures in therapeutic trials.

To cite this abstract in AMA style:

F. Niccolini, G. Pagano, P. Fusar-Poli, A. Wood, L. Mrzljak, C. Sampaio, M. Politis. Striatal molecular alterations in Huntington’s disease gene expansion carriers: A systematic review and meta-analysis of PET studies [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/striatal-molecular-alterations-in-huntingtons-disease-gene-expansion-carriers-a-systematic-review-and-meta-analysis-of-pet-studies/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/striatal-molecular-alterations-in-huntingtons-disease-gene-expansion-carriers-a-systematic-review-and-meta-analysis-of-pet-studies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley